Lymphocyte-derived microRNA hsa-miR-150-5p as a marker of inflammation-related kidney function impairment in the

Sandra Van der Auwera1, Tim Lange2, Tilman Schmidt3

  • 1Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany; German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.

Insights

This study found miR-150-5p plasma levels are linked to kidney function and disease. It may serve as an early indicator for subclinical kidney disease, independent of lymphocytes.

Area of Science:

  • Immunology
  • Molecular Biology
  • Nephrology

Background:

  • MicroRNAs (miRNAs) are implicated in immune regulation and disease.
  • Previous research suggests links between miRNAs, lymphocytes, and immune markers.

Purpose of the Study:

  • To investigate the relationship between plasma miRNAs, lymphocytes, cardiometabolic diseases, and clinical parameters.
  • To identify specific miRNAs associated with kidney function and disease.

Main Methods:

  • Analysis of the population-based SHIP-TREND cohort (N=804).
  • Linear regression to identify associations between plasma miRNAs and clinical parameters.
  • Validation in independent public clinical datasets.

Main Results:

  • miR-150-5p was strongly associated with lymphocytes in both study waves.
  • miR-150-5p showed significant associations with kidney disease and renal function markers.
  • These associations were independent of lymphocytes and indicated a transition to subclinical disease.

Conclusions:

  • miR-150-5p may mediate the effects of lymphocytes on kidney disease by regulating gene expression and inflammatory pathways.
  • miR-150-5p is a potential early biomarker for subclinical kidney disease.
  • Further research into miR-150-5p's role in kidney pathology is warranted.

Related Concept Videos